The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 495K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Vinuesa, C. G.
Right arrow Articles by MacLennan, I. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Vinuesa, C. G.
Right arrow Articles by MacLennan, I. C.M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/2/485/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 3, February 7, 2000 485-494


Original Article

Germinal Centers without T Cells

Carola García de Vinuesaa, Matthew C. Cooka, Jennifer Balla, Marion Drewa, Yvonne Sunnersa, Marilia Cascalhob, Matthias Wablb, Gerry G.B. Klausc, and Ian C.M. MacLennana
a From the Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham B15 2TT, United Kingdom
b Department of Microbiology and Immunology, University of California, San Francisco, California 94103-0670
c Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom

Correspondence to: Ian C.M. MacLennan, MRC/University of Birmingham Centre for Immune Regulation, University of Birmingham, Birmingham B15 2TT, UK. Tel:44-121-414-4068 Fax:44-121-414-3599 E-mail:i.c.m.maclennan{at}bham.ac.uk.

Germinal centers are critical for affinity maturation of antibody (Ab) responses. This process allows the production of high-efficiency neutralizing Ab that protects against virus infection and bacterial exotoxins. In germinal centers, responding B cells selectively mutate the genes that encode their receptors for antigen. This process can change Ab affinity and specificity. The mutated cells that produce high-affinity Ab are selected to become Ab-forming or memory B cells, whereas cells that have lost affinity or acquired autoreactivity are eliminated. Normally, T cells are critical for germinal center formation and subsequent B cell selection. Both processes involve engagement of CD40 on B cells by T cells. This report describes how high-affinity B cells can be induced to form large germinal centers in response to (4-hydroxy-3-nitrophenyl) acetyl (NP)-Ficoll in the absence of T cells or signaling through CD40 or CD28. This requires extensive cross-linking of the B cell receptors, and a frequency of antigen-specific B cells of at least 1 in 1,000. These germinal centers abort dramatically at the time when mutated high-affinity B cells are normally selected by T cells. Thus, there is a fail-safe mechanism against autoreactivity, even in the event of thymus-independent germinal center formation.

Key Words: quasimonoclonal mice, (4-hydroxy-3-nitrophenyl)acetyl–Ficoll, germinal centers, CD40 ligation, thymus independent


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS